Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders.

Ram M, Anaya JM, Barzilai O, Izhaky D, Porat Katz BS, Blank M, Shoenfeld Y.

Autoimmun Rev. 2008 Sep;7(8):621-5. doi: 10.1016/j.autrev.2008.06.008. Epub 2008 Jul 9.

PMID:
18603025
2.

[The hepatitis B virus as a probable etiological factor in Sjögren's disease].

Aprosin ZG, Serov VV, Lopatkina TN.

Ter Arkh. 1993;65(4):73-8. Russian.

PMID:
8059413
3.

The prevalence of occult hepatitis B virus infection in type 2 diabetes mellitus patients.

Demir M, Serin E, Göktürk S, Ozturk NA, Kulaksizoglu S, Ylmaz U.

Eur J Gastroenterol Hepatol. 2008 Jul;20(7):668-73. doi: 10.1097/MEG.0b013e3282f55e1e.

PMID:
18679070
4.

[Prevalance of antibodies against hepatitis C and B viruses in patients with systemic lupus erythematosus].

Mercado U, Avendaño-Reyes M, Araiza-Casillas R, Díaz-Molina R.

Rev Gastroenterol Mex. 2005 Oct-Dec;70(4):399-401. Spanish.

PMID:
17058978
5.

Suitability of yeast- and Escherichia coli-expressed hepatitis B virus core antigen derivatives for detection of anti-HBc antibodies in human sera.

Li ZX, Hong GQ, Hu B, Liang MJ, Xu J, Li L.

Protein Expr Purif. 2007 Dec;56(2):293-300. Epub 2007 Aug 24.

PMID:
17897838
6.

Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.

Han Y, Tang Q, Zhu W, Zhang X, You L.

J Gastroenterol Hepatol. 2008 Nov;23(11):1728-33. doi: 10.1111/j.1440-1746.2008.05600.x. Epub 2008 Sep 24.

PMID:
18823435
7.

Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report.

Barzilai O, Sherer Y, Ram M, Izhaky D, Anaya JM, Shoenfeld Y.

Ann N Y Acad Sci. 2007 Jun;1108:567-77.

PMID:
17894021
8.

Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.

Katz L, Strong DM, Tegtmeier G, Stramer S.

Transfusion. 2008 Nov;48(11):2315-22. doi: 10.1111/j.1537-2995.2008.01844.x. Epub 2008 Jul 17.

PMID:
18647367
9.

Retroviruses in autoimmune liver disease: genetic or environmental agents?

Mason AL, Xu L, Guo L, Garry RF.

Arch Immunol Ther Exp (Warsz). 1999;47(5):289-97. Review.

PMID:
10604234
10.

High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.

Said ZN, El-Sayed MH, El-Bishbishi IA, El-Fouhil DF, Abdel-Rheem SE, El-Abedin MZ, Salama II.

Liver Int. 2009 Apr;29(4):518-24. doi: 10.1111/j.1478-3231.2009.01975.x. Epub 2009 Jan 22.

PMID:
19192168
11.

Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.

Goules A, Tzioufas AG, Manousakis MN, Kirou KA, Crow MK, Routsias JG.

J Autoimmun. 2006 May;26(3):165-71. Epub 2006 Apr 18.

PMID:
16621447
12.

Donor screening for hepatitis B virus infection in a cell and tissue bank.

Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ.

Transpl Infect Dis. 2008 Dec;10(6):391-5. doi: 10.1111/j.1399-3062.2008.00331.x. Epub 2008 Jul 28.

PMID:
18665905
13.

Hepatitis B virus infection in patients with systemic lupus erythematosus.

Chng HH, Fock KM, Chew CN, Guan R, Feng PH, Boey ML, Chee EN, Chua KL.

Singapore Med J. 1993 Aug;34(4):325-6.

PMID:
8266204
14.

Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.

Sukriti, Pati NT, Sethi A, Agrawal K, Agrawal K, Kumar GT, Kumar M, Kaanan AT, Sarin SK.

J Gastroenterol Hepatol. 2008 Nov;23(11):1710-5. doi: 10.1111/j.1440-1746.2008.05483.x. Epub 2008 Aug 28.

PMID:
18761556
15.

Impact of a policy to permit the return of donors repeat-reactive to the Abbott PRISM antibody to hepatitis B core antigen assay.

O'Brien SF, Yi QL, Fan W, Fearon MA, Scalia V, Goldman M.

Transfusion. 2009 Feb;49(2):271-7. doi: 10.1111/j.1537-2995.2008.01973.x.

PMID:
19389210
16.
17.

Re-evaluation of anti-HBc non-reactive serum samples from patients with persistent hepatitis B infection by immune precipitation with labelled HBV core antigen.

Kantelhardt VC, Schwarz A, Wend U, Schüttler CG, Willems WR, Trimoulet P, Fleury H, Gerlich WH, Kann M.

J Clin Virol. 2009 Oct;46(2):124-8. doi: 10.1016/j.jcv.2009.06.018. Epub 2009 Jul 24.

PMID:
19631583
18.

Lack of implementation of Hepatitis B Virus (HBV) vaccination policy in household contacts of HBV carriers in Italy.

Scognamiglio P, Girardi E, Fusco M, Piselli P, Spena SR, Maione C, Pisanti FA, Serraino D; Collaborating Study Group.

BMC Infect Dis. 2009 Jun 7;9:86. doi: 10.1186/1471-2334-9-86.

19.

The role of infections in the immunopathogensis of systemic sclerosis--evidence from serological studies.

Arnson Y, Amital H, Guiducci S, Matucci-Cerinic M, Valentini G, Barzilai O, Maya R, Shoenfeld Y.

Ann N Y Acad Sci. 2009 Sep;1173:627-32. doi: 10.1111/j.1749-6632.2009.04808.x.

PMID:
19758208
20.

Vertical transmission of hepatitis B virus (HBV) from mothers negative for HBV surface antigen and positive for antibody to HBV core antigen.

Walz A, Wirth S, Hucke J, Gerner P.

J Infect Dis. 2009 Oct 15;200(8):1227-31. doi: 10.1086/605698.

PMID:
19751152

Supplemental Content

Support Center